中文 | English
Return
Total: 127 , 1/13
Show Home Prev Next End page: GO
Author:(Hailong WU)

1.Finite element analysis of implants with different crown-to-implant ratios under different bone conditions

Zirui KANG ; Yang WU ; Hailong SONG ; Qiaoyun YANG ; Lixiang ZANG ; Dongliang XU

Chinese Journal of Tissue Engineering Research 2026;30(2):319-328

2.Finite element analysis of implants with different crown-to-implant ratios under different bone conditions

Zirui KANG ; Yang WU ; Hailong SONG ; Qiaoyun YANG ; Lixiang ZANG ; Dongliang XU

Chinese Journal of Tissue Engineering Research 2026;30(2):319-328

3.Hypoxia inducible factor 1 and depressive disorder

Lan WU ; Yinping XIE ; Hailong GE ; Chen LI ; Junjie HUANG ; Lujia SI ; Ling XIAO ; Gaohua WANG

Chinese Journal of Behavioral Medicine and Brain Science 2025;34(4):375-379

4.Hypoxia inducible factor 1 and depressive disorder

Lan WU ; Yinping XIE ; Hailong GE ; Chen LI ; Junjie HUANG ; Lujia SI ; Ling XIAO ; Gaohua WANG

Chinese Journal of Behavioral Medicine and Brain Science 2025;34(4):375-379

5.Establishment and evaluation of a mouse model of acute exacerbation of interstitial pulmonary fibrosis

Wenjing WU ; Siyuan ZHU ; Xingjie SANG ; Qin ZHANG ; Peng ZHAO ; Hailong ZHANG ; Yunping BAI

Chinese Journal of Pathophysiology 2025;41(4):816-824

6.Advances in basic research on transient receptor potential vanilloid 1 channel in the pathogenesis and treatment of major depressive disorder

Junjie HUANG ; Yinping XIE ; Hailong GE ; Chen LI ; Lujia SI ; Lan WU ; Ling XIAO ; Gaohua WANG

Chinese Journal of Psychiatry 2025;58(1):69-74

7.Effect of performance of pneumatic logistics transmission system on quality of laboratory medicine

Hailong WANG ; Jing WU ; Xiaoya ZHENG ; Yaping WANG ; Lili CHEN ; Zhenbao SONG ; Xun CHEN

International Journal of Laboratory Medicine 2025;46(12):1498-1502

8.Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance.

Siqi ZHANG ; Xiaohui MA ; Jiang WU ; Jieting SHEN ; Yuntao SHI ; Xingkai WANG ; Lin XIE ; Xiaona SUN ; Yuxuan WU ; Hao TIAN ; Xin GAO ; Xueyao CHEN ; Hongyi HUANG ; Lu CHEN ; Xuekai SONG ; Qichen HU ; Hailong ZHANG ; Feng WANG ; Zhao-Hui JIN ; Ming-Rong ZHANG ; Rui WANG ; Kuan HU

Acta Pharmaceutica Sinica B 2025;15(2):692-706

9.Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation.

Yuxuan WU ; Xingkai WANG ; Xiaona SUN ; Xin GAO ; Siqi ZHANG ; Jieting SHEN ; Hao TIAN ; Xueyao CHEN ; Hongyi HUANG ; Shuo JIANG ; Boyang ZHANG ; Yingzi ZHANG ; Minzi LU ; Hailong ZHANG ; Zhicheng SUN ; Ruping LIU ; Hong ZHANG ; Ming-Rong ZHANG ; Kuan HU ; Rui WANG

Acta Pharmaceutica Sinica B 2025;15(9):4511-4542

10.A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer.

Kun WANG ; Cong WANG ; Hange YANG ; Gong CHEN ; Ke WANG ; Peihong JI ; Xudong SUN ; Xuegong FAN ; Jie MA ; Zhencun CUI ; Xingkai WANG ; Hao TIAN ; Dengfu WU ; Lu WANG ; Zhimin WANG ; Jiangyan LIU ; Juan YI ; Kuan HU ; Hailong ZHANG ; Rui WANG

Acta Pharmaceutica Sinica B 2025;15(10):4995-5009

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 127 , 1/13 Show Home Prev Next End page: GO